A wider consideration of your overall health and wellness should also play a part in your decision to seek this type of treatment
It will not suit those managing other health conditions who need comprehensive and clearly defined care
Jastreboff, MD, PhD Director, Weight Management & Obesity Prevention Yale School of Medicine, New Haven, Connecticut Professor Ania Jastreboff has been a principal investigator for pivotal GLP3 clinical trials, including the landmark phase 2 obesity study published in the New England Journal of Medicine
ID 1100151587 Flavor: Neutral Sold and shipped by FITADIUM Trusted Decathlon Partner Online exclusive
Patients in Stamford, Greenwich, Fairfield County, and throughout Connecticut can call 203-348-8805 to discuss whether GLP-1 therapy, semaglutide, tirzepatide, or another medically supervised weight-loss option may be appropriate